Drawing for CENCORA

USPTO serial 97765170

CENCORA

Reviewed by CopyMark Law Group

Reg. 8470962Status 700Registered
Filing date
Status date
Registration date
Sep 29, 2026
Examiner
DUBIN, DAVID I
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CENCORA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anita B. Polott

Anita B. Polott MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE, NWATTENTION: TMSUWASHINGTON, DC 20004-2541

Goods and services

ClassDescriptionStatusFirst use
044Medical analysis services, namely, medical diagnostic testing, monitoring and reporting in the field of human disease treatment; providing medical information being a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices being the specific diagnosis, line of therapy, stage of disease and regimen information; providing clinical and home health care services, namely, providing medical and healthcare information relating to therapeutic properties of pharmaceuticals; providing medical counseling and healthcare counseling being health counseling to patients in the field of administration of medications; providing medical clinic and health clinic services; home health care services; providing medical care information being medical information; Health care services, namely, providing wellness programs for disease treatment and management featuring patient-centered incentives for compliance with physician-directed educational, medication therapy, and home care programs; providing medical, health and veterinary information services for the pharmaceutical and medical sectors; providing medical information services in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for the pharmaceutical and medical sectors; providing medical and health counseling and pharmaceutical advice services related to workplace and personnel health; healthcare services; providing medical and healthcare information on medical substances; medical and healthcare consulting being consultancy services relating to medical care and health care in the field of analyzing and reporting of discussions about human disease treatment; medical services being administration and management of sophisticated pharmaceutical therapies; providing medical information, health information, veterinary information, pharmaceutical advice and biotechnical information being healthcare information via a website; remote healthcare and telemedicine services being healthcare services provided via telecommunication in the nature of remote monitoring of data indicative of the health or condition of a patient for medical treatment purposes; remote healthcare and telemedicine services being providing patients with health information relating to their medical condition; beauty consultancy and health care consulting services; providing nursing services to others on behalf of pharmaceutical and biotechnology companies; providing health and nutrition information in the field of animal management; medical consulting, healthcare consulting, and veterinary consulting services in the field of animal, medical and healthcare management, and in the field of research, development, analysis and identification of processes to efficiently raise individual animalsACTIVEAug 30, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 29, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 9, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 9, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 25, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 13, 2026IUAFUSE AMENDMENT FILED—
Jul 13, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 14, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 13, 2026EX2GSOU EXTENSION 2 GRANTED—
Jan 13, 2026EXT2SOU EXTENSION 2 FILED—
Jan 13, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 10, 2025EX1GSOU EXTENSION 1 GRANTED—
Jul 10, 2025EXT1SOU EXTENSION 1 FILED—
Jul 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 14, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 3, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 3, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 27, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 11, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 11, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Nov 11, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 11, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 11, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 5, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 5, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 5, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 18, 2024AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Apr 18, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 16, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jan 16, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Oct 19, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2023DOCKASSIGNED TO EXAMINER—
Oct 18, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 21, 2023AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jul 21, 2023ALIEASSIGNED TO LIE—
Jul 14, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Feb 13, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 26, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance